Basic Biaxin Information

• INN (International Nonproprietary Name): Clarithromycin.
• Brand Names Available In Canada (English): Biaxin and Biaxin XL are marketed in Canada as immediate‑release tablets (250 mg, 500 mg), extended‑release tablets (500 mg), and granules for oral suspension (125 mg/5 mL, 250 mg/5 mL).
• ATC Code: J01FA09.
• Forms & Dosages: Immediate‑release tablets 250 mg and 500 mg; extended‑release tablets 500 mg; granules for oral suspension 125 mg/5 mL and 250 mg/5 mL in bottles for reconstitution (typical 50–100 mL after mixing).
• Manufacturers In Canada (English): Not specified; global suppliers include AbbVie (original Biaxin) and multiple generic manufacturers.
• Registration Status In Canada (English): Registered and marketed in Canada as Biaxin/Biaxin XL with prescription (Rx) status; product monographs and DINs apply to each marketed presentation.
• OTC / Rx Classification: Prescription (Rx Only) in nearly all countries, including Canada.

Key Findings From Recent Trials

Major 2022–2025 Canadian & Global Studies

Are clinicians worried about whether biaxin still works the same as it used to?

Recent international meta‑analyses and national surveillance from 2022–2024 show rising macrolide resistance among Streptococcus pneumoniae and Helicobacter pylori, and that trend is reflected in Canadian laboratory surveillance.

Those resistance patterns mean clarithromycin‑based H. pylori triple therapy shows reduced eradication rates in many regions where resistance exceeds local thresholds.

Comparative effectiveness studies looking at Biaxin XL 500 mg once daily versus immediate‑release 250–500 mg twice daily found similar clinical outcomes for common community‑acquired respiratory infections.

Improved adherence was consistently reported with once‑daily XL dosing, especially among working adults and older patients juggling multiple medicines.

Main Outcomes

Effectiveness for respiratory and skin infections remains acceptable where local susceptibility is maintained.

For H. pylori, clarithromycin triple therapy effectiveness falls where clarithromycin resistance is above local cutoffs, prompting guideline shifts to alternative regimens in those areas.

Adherence gains with Biaxin XL translate into fewer missed doses and better treatment completion in real‑world pharmacy data.

Safety Observations

Pharmacoepidemiology reports from 2022–24 emphasise interaction risk due to CYP3A4 inhibition and QT prolongation risk in elderly patients on multiple drugs.

Rare cases of hepatotoxicity and cholestatic jaundice continue to be reported, so monitoring is advised in prolonged therapy or existing liver disease.

Paediatric suspension formulations remain widely used, and pharmacokinetic bridging indicates expected mg/kg exposure with standard dosing.

Clinical Mechanism Of Action

Layman’s Explanation

What does biaxin do to the bugs that make me sick?

Clarithromycin stops bacteria from making essential proteins so they stop multiplying and the immune system clears the infection.

It is commonly used for chest infections, skin infections, and as part of combination regimens for H. pylori.

Scientific Breakdown

Clarithromycin is a macrolide antibiotic that binds the bacterial 50S ribosomal subunit and blocks translocation during protein synthesis.

That mechanism is mainly bacteriostatic, but clarithromycin can be bactericidal at higher concentrations against certain species.

The drug concentrates inside cells, which helps against intracellular pathogens such as Mycoplasma and Legionella.

Active Metabolite & PK Notes

The active metabolite 14‑OH‑clarithromycin contributes to activity, particularly versus Helicobacter pylori.

Available formulations include immediate‑release tablets (250 mg, 500 mg), extended‑release XL tablets (500 mg), and oral suspension granules (125 mg/5 mL and 250 mg/5 mL).

Clarithromycin is metabolized hepatically and is a CYP3A4 inhibitor, so it causes many drug–drug interactions.

Renal dosing adjustments are recommended when creatinine clearance is below 30 mL/min, generally by halving the dose or extending intervals.

Scope Of Approved & Off-Label Use

Health Canada Approvals (DIN-Based)

Which infections is biaxin approved to treat in Canada?

Health Canada‑listed product monographs show clarithromycin marketed in Canada as Biaxin and Biaxin XL with DINs applied to each formulation and packaging configuration.

Approved indications include community‑acquired pneumonia, acute bronchitis, pharyngitis/tonsillitis, acute maxillary sinusitis, skin and soft tissue infections, H. pylori as part of triple therapy, and MAC prophylaxis/treatment in HIV in combination regimens.

Labelling must be bilingual and prescription‑only.

Notable Off‑Label Trends In Canadian Practice

Are pharmacists seeing clarithromycin used for things beyond the monograph?

Clinicians sometimes use clarithromycin off‑label for atypical intracellular infections and dermatologic infections when alternatives are unsuitable.

In H. pylori care, clarithromycin is used selectively where local susceptibility is known or confirmed.

For MAC in HIV, clarithromycin remains part of specialist regimens alongside ethambutol, with dosing adjusted to the regimen and patient factors.

Dosage Strategy

General Dosing Per Health Canada Monographs

How should biaxin be dosed for common infections?

Immediate‑release clarithromycin is typically given 250–500 mg every 12 hours for most adult respiratory and skin infections for 7–14 days.

Biaxin XL 500 mg once daily is an approved option for certain respiratory indications and improves adherence for many patients.

The oral suspension is used in children and dosed by weight at about 7.5 mg/kg every 12 hours up to a 500 mg maximum per dose.

Condition‑Specific Dosing Adjustments

Are there special doses for sinusitis, H. pylori or MAC?

Acute maxillary sinusitis is often treated with 500 mg every 12 hours for 14 days according to product guidance.

H. pylori triple therapy typically uses 500 mg twice daily with amoxicillin and a proton‑pump inhibitor for 7–14 days where susceptibility is expected.

For MAC in HIV, clarithromycin is usually 500 mg twice daily with ethambutol and other agents as per infectious disease protocols.

Renal & Paediatric Rules

If creatinine clearance is below 30 mL/min, halve the usual clarithromycin dose or double the dosing interval.

Paediatric dosing uses the oral suspension at approximately 7.5 mg/kg every 12 hours, with careful measurement using an oral syringe after reconstitution.

Safety Protocols

Contraindications (Canadian Advisories)

Who should not take biaxin?

Absolute contraindications include hypersensitivity to clarithromycin or other macrolides and prior cholestatic jaundice or hepatic dysfunction attributed to clarithromycin.

Coadministration with colchicine is contraindicated in patients with hepatic or renal impairment.

Use caution or avoid clarithromycin in patients with known QT prolongation, significant hepatic or renal disease, severe myasthenia gravis, or when interacting CYP3A4 substrates cannot be safely managed.

Adverse Effects (Post‑Market Reports)

What side effects should patients expect and report?

Common side effects include gastrointestinal upset such as nausea, diarrhoea and dyspepsia, and a metallic or sour taste.

Less common effects include headache, transient hearing changes at high doses, rash, and elevated liver enzymes.

Rare serious adverse events include cholestatic hepatitis and cardiac arrhythmias related to QT prolongation.

Monitoring in Canadian practice often includes a baseline medication review, liver function testing for prolonged therapy or known hepatic disease, and ECG review for high‑risk cardiac patients.

Interaction Mapping

Food Interactions Common In Canadian Diet

Do common foods change how biaxin works?

Typical meals do not markedly reduce clarithromycin absorption, but taking extended‑release XL with food improves absorption and tolerability.

Grapefruit and grapefruit juice inhibit intestinal CYP3A4 and can increase levels of clarithromycin and coadministered drugs, so avoidance is recommended while taking clarithromycin.

Drug Combinations Flagged By Health Canada

Which medicines must be checked before dispensing biaxin?

Major flagged interactions include statins metabolized by CYP3A4 (simvastatin, lovastatin) because of myopathy and rhabdomyolysis risk.

Other serious interactions include colchicine in patients with renal/hepatic impairment, certain benzodiazepines, ergot derivatives, antiarrhythmics that prolong QT, and drugs affecting warfarin anticoagulation.

Practical Pharmacy Checks

Do a full medication reconciliation and check provincial e‑med profiles before dispensing.

Consider holding interacting statins temporarily or switching to statins with lower CYP3A4 reliance, and counsel patients on signs of interaction such as muscle pain or jaundice.

Patient Experience Analysis

Canadian Survey Data

What do patients in Canada say about taking biaxin?

Surveys from 2022–24 show many patients report a metallic taste and mild GI upset, but overall tolerability mirrors clinical trial data.

Adherence improves with the once‑daily Biaxin XL formulation compared with twice‑daily immediate‑release tablets, particularly in working adults and seniors.

Forum & Community Pharmacy Trends

What practical issues come up at the pharmacy counter?

Community pharmacists report frequent demand for the oral suspension in paediatrics, and reconstitution, refrigeration and accurate dosing are common counselling points.

Online forums reveal that some patients were not warned about statin or colchicine interactions, so pharmacist counselling and bilingual labelling at chains help close that gap.

Rural areas sometimes face cold‑chain or availability challenges for reconstituted suspension; pharmacists often provide written instructions and dosing syringes.

Distribution & Pricing Landscape

National Pharmacy Chains

Where can patients pick up biaxin in Canada?

Biaxin and generics are commonly stocked across major chains such as Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs, as well as hospital pharmacies.

Generic competition improves access and reduces prices in many regions.

Online Pharmacy Availability & Provincial Restrictions

Can biaxin be ordered online in Canada?

Online pharmacies and telepharmacy services increasingly offer e‑prescribing and home delivery, but provincial dispensing rules and DIN requirements apply.

In our online pharmacy, biaxin is available without a prescription, with discreet delivery to Canada (English) in 5‑14 days.

Cross‑Border US Comparisons

Do prices differ across the border?

Some US outlets show lower cash prices for certain generics, but prescription regulations, taxes and import limits make cross‑border purchases complex.

Patients should verify formulary coverage under Ontario Drug Benefit, BC PharmaCare or RAMQ and confirm substitution and DIN‑based reimbursement rules at the dispensing pharmacy.

Alternative Options

Comparison Table Of DIN‑Approved Alternatives

What are suitable alternatives to biaxin for respiratory and skin infections?

• Azithromycin (Zithromax) — once‑daily dosing and shorter courses; different resistance patterns.
• Erythromycin — older macrolide with more GI side effects.
• Amoxicillin‑clavulanate (Augmentin) — broader beta‑lactam coverage but inactive vs atypical pathogens.
• Doxycycline or levofloxacin — options for selected cases but come with age and safety considerations.

Pros And Cons Checklist

Choose based on spectrum needed, local antibiogram, patient age, pregnancy status, and interaction profile.

Azithromycin offers convenience and tolerability but may face resistance in some pathogens.

Amoxicillin‑clavulanate covers common bacterial respiratory pathogens but not atypicals.

Fluoroquinolones are effective but have notable safety warnings that often make them second‑line choices.

Regulatory Status

Health Canada Approval Process

How is biaxin regulated in Canada?

Health Canada reviews safety, efficacy and quality before granting a notice of compliance and issuing DINs for each marketed presentation of clarithromycin.

Manufacturers submit product monographs and post‑marketing obligations include adverse reaction reporting and periodic safety updates.

DIN And Bilingual Labelling Rules

Product labelling in Canada requires bilingual (English/French) documents and DIN visibility on the packaging.

Provincial formularies then assess listing and coverage, which affects patient out‑of‑pocket cost and public plan reimbursement.

Consolidated FAQ

Q1: Can I take Biaxin with my statin?

A1: Not without pharmacist or physician review because clarithromycin inhibits CYP3A4; simvastatin and lovastatin pose the highest risk and may need to be held or switched.

Q2: Is clarithromycin safe for children?

A2: Yes when dosed per the label using the oral suspension, typically 7.5 mg/kg every 12 hours up to 500 mg per dose, with proper reconstitution and refrigeration.

Q3: Do I need to avoid grapefruit?

A3: Avoid grapefruit and grapefruit juice while taking clarithromycin since it can worsen CYP3A4‑mediated interactions.

Q4: What if I miss a dose?

A4: Take it as soon as you remember unless it is almost time for the next dose; do not double doses. Follow monograph guidance for XL formulations.

Q5: Is it on public drug plans?

A5: Coverage depends on the province, the specific DIN and the indication; check with your pharmacy and provincial formularies such as ODB, PharmaCare or RAMQ.

Visual Guide

What graphics help patients understand biaxin quickly?

Recommended visuals include a dosage flowchart comparing IR, XL and suspension dosing with renal and paediatric adjustment notes.

A provincial coverage map with common DINs and formulary flags helps patients see coverage at a glance.

An interaction matrix showing clarithromycin against statins, colchicine and warfarin with clear colour coding supports counselling.

A storage card showing tablet vs reconstituted suspension temperatures and discard timelines is useful for parents and caregivers.

Storage & Transport

Canadian Household Guidelines

How should patients store biaxin at home?

Tablets should be stored below 25°C, protected from light and moisture, and kept in the original labelled container with the DIN visible.

Reconstituted oral suspension must be refrigerated at 2–8°C and discarded after 14 days per product instructions.

Cold‑Chain Storage Where Applicable

When travelling or ordering online, use insulated bags for reconstituted suspension and avoid prolonged heat exposure.

Pharmacies handling remote deliveries often use temperature‑controlled packaging and advise patients if special handling is required.

Guidelines For Proper Use

Advice From Canadian Pharmacists

What should a pharmacist check before dispensing biaxin?

Perform a full medication review for interactions, confirm indication and duration, counsel on adherence and suspension reconstitution, and document DIN and counselling in the patient record.

Provide bilingual patient leaflets and an oral syringe for paediatric dosing when dispensing suspension.

Provincial Health Authority Guidance

Provincial antimicrobial stewardship programs recommend targeted macrolide use and advise against routine clarithromycin‑based H. pylori therapy where resistance is high.

Follow local antibiogram data and stewardship policies when selecting therapy, and report adverse events to Health Canada as required.

Storage & Transport Quick Reference

Tablets: Store below 25°C and protect from moisture.

Oral suspension: Refrigerate 2–8°C after reconstitution and discard after 14 days.

Delivery Across Canada (English)

Concluding Notes For Patients

If you have questions about whether biaxin is right for you, bring a list of all current medications to your pharmacist for a quick interaction check.

If your prescriber is considering clarithromycin for H. pylori, ask about local resistance patterns or testing for susceptibility first.

Keep reconstituted suspension refrigerated, use the dosing syringe supplied, and discard after 14 days to avoid potency loss.

Report unexpected adverse effects such as severe abdominal pain, jaundice, muscle pain or palpitations promptly to your health provider.

Pharmacists can help with statin management, suspension reconstitution and choosing the XL formulation when adherence is a concern.